Back to Search
Start Over
Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.
- Source :
- Neurology® Neuroimmunology & Neuroinflammation; Mar2023, Vol. 10 Issue 2, p1-10, 10p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 23327812
- Volume :
- 10
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Neurology® Neuroimmunology & Neuroinflammation
- Publication Type :
- Academic Journal
- Accession number :
- 163107063
- Full Text :
- https://doi.org/10.1212/NXI.0000000000200083